Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01901393 · ClinicalTrials.gov registry record · Phase 4

Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery

A Phase 4 study, sponsored by Cumberland Pharmaceuticals.

Completed
Registry status
Phase 4
Development phase
100
Enrollment target

NCT01901393: Completed Phase 4 study, sponsored by Cumberland Pharmaceuticals.

NCT01901393 is a Phase 4 study that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01901393, a Phase 4 study, has completed, sponsored by Cumberland Pharmaceuticals.

COMPLETED
Registry status
Phase 4
Development phase
100 participants
Enrollment target

Study Summary

The purpose of this study is to assess the efficacy of intravenous ibuprofen compared to ketorolac for the treatment of postoperative pain as measured by patient pain intensity (Visual Analog Scale, VAS)

Primary Outcome

Pain assessed using VAS (Visual Analog Scale, VAS). The VAS is a continuous scale compromised of a horizontal line, one hundred millimeters in length, anchored by 2 verbal descriptors (No Pain, Worst Possible Pain). The VAS is self-completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity. Using a ruler, the score is determined by measuring the distance, in mm, on the 100 mm line between the "No Pain" anch

Interventions

  • DRUG Ketorolac
  • DRUG IV ibuprofen

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2013-07
Est. Completion 2014-08
Phase Phase 4
Cumberland Pharmaceuticals

43 total trials

What the finished NCT01901393 record still lists

NCT01901393 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.

NCT01901393 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01901393 about?

NCT01901393 is a clinical study titled "Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery". The purpose of this study is to assess the efficacy of intravenous ibuprofen compared to ketorolac for the treatment of postoperative pain as measured by patient pain intensity (Visual Analog Scale, VAS)

What is the current status of trial NCT01901393?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2013-07. Estimated completion is 2014-08.

What interventions are being tested in trial NCT01901393?

The interventions under investigation include: Ketorolac (DRUG), IV ibuprofen (DRUG).

Who is sponsoring clinical trial NCT01901393?

This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01901393's enrollment target sits among peer trials

100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01901393, the US trial registry maintained by the National Library of Medicine. NCT01901393 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.